Confirming a mechanistic role for NK cells in the antitumor effects of sIL18, IL18-overexpressing B16-F10 melanomas progressed as rapidly as their IL18D69A-overexpressing counterparts in C57BL/6 mice subjected to the antibody-dependent depletion of NK cells.1 Here, IL18 is linked to melanoma.